Relative Timing of Radiotherapy and Androgen Deprivation for Prostate Cancer and Implications for Treatment During the COVID-19 Pandemic
Edward Christopher Dee, Brandon A. Mahal, Melaku A. Arega, Anthony V. D’Amico, Kent W. Mouw, Paul L. Nguyen, Vinayak Muralidhar
Abstract
This cohort study uses National Cancer Database data from 2004 to 2014 to examine the association between overall survival and timing of radiotherapy relative to androgen deprivation therapy in patients with prostate cancer.
Topics & Concepts
MedicineProstate cancerAndrogen deprivation therapyRadiation therapyPandemicOncologyCohortCohort studyCoronavirus disease 2019 (COVID-19)Internal medicineEnzalutamideAndrogenCancerDiseaseAndrogen receptorHormoneInfectious disease (medical specialty)COVID-19 and healthcare impactsProstate Cancer Diagnosis and TreatmentEconomic and Financial Impacts of Cancer